VerifiedRx Vizient Center for Pharmacy Practice Excellence
-
- Salud y forma física
Delivering short doses of insight for hospitals’ frontline pharmacists, Vizient pharmacy leader Gretchen Brummel brings together experts to verify best practices for navigating today’s pharmacy practice challenges and accelerating career growth. It’s a prescription for success, delivered by the Vizient Center for Pharmacy Practice Excellence.
-
The drug shortage specialist will see you now
The incredible staying power of drug shortages kicks the door open for full-time pharmacy roles designed to combat this issue. Dr. Austin Pytlowany, clinical pharmacist specialist in drug shortage management at Michigan Medicine and Vizient's Kyle Hoelting, senior clinical manager of drug shortages and drug information join host Gretchen Brummel, Pharmacy Executive Director with the Vizient Center for Pharmacy Practice Excellence to discuss drug shortages and drug information and share their perspectives.
Guest speakers: Austin Pytlowany, PharmDPharmacy Manager – Inventory and Drug Shortage ManagementMichigan Medicine
Kyle Hoelting, PharmD, BCPSSr. Clinical Manager of Drug Information and ShortagesVizient Center for Pharmacy Practice Excellence
Host: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence
Show Notes:
[00:48-01:53] Dr. Pytlowany background information
[01:54-02:52] Why Michigan Medicine created his position
[02:53-05:52] The overall impact of drug shortages right now
[05:53-07:12] National impact of drug shortages
[07:13-10:41] Austin’s position helping improving patient care at Michigan Medicine
[10:42-12:25] Organizational benefits of individuals or a teams dedicated to drug shortages
[12:26-16:41] Other kinds of positions out there
[16:42-20:40] Concepts and solutions coming out of this or to market
[20:41-22:11] Future for these types of roles in drug shortages
[22:12-25:38] Advice for people who want to get into this specialty
Links | Resources:
The One Thing You Need to Know about Drug Shortage Stewardship
Drug Shortage Stewardship: Calls to Action for the Interconnected Supply Chain
ASHP Current Drug Shortages
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Android
RSS Feed
-
Cultivating infusion services from every angle
Health system pharmacies are turning to outpatient infusion services to improve financial performance as margins shrink. Dr. Zinkeng Asonganyi, Director of Ambulatory Pharmacy and Infusion Services at University of Texas Medical Branch or UTMB Health discusses the program and it’s implications with host Gretchen Brummel, Pharmacy Executive Director with the Vizient Center for Pharmacy Practice Excellence.
Guest speakers: Zinkeng Asonganyi, PharmDDirector of Ambulatory Pharmacy OperationsUTMB
Host: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence
Show Notes:
[00:52-01:38] Dr. Asonganyi background information
[01:39-06:44] What’s happening in infusion at UTMB
[06:45-12:15] Complexities and logistics of the program
[12:16-15:13] Maintaining and growing reimbursement in this time of challenges
[15:14-18:33] Biggest opportunities for enhancement or growth
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Android
RSS Feed
-
Special Delivery: Impacts of Specialty Pharmacy
A big part of total national drug spend is the continuing growth of the specialty drug market. Health systems depend on specialty pharmacy to make up margin losses from other areas. Dr. Vinay Eapen, Senior Manager of Specialty Pharmacy at University of Texas Medical Branch, joins Gretchen Brummel, Pharmacy Executive Director in the Vizient Center for Pharmacy Practice Excellence and your program to share a bold approach to starting specialty pharmacy services at an academic medical center.
Guest speakers:
Vinay Eapen, PharmD
UTMB Senior Specialty Pharmacy Manager
Lean Adjunct Faculty
UTMB Department of Pharmacy
Host:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
Show Notes:
[00:46-01:09] Dr. Eapen background information
[01:10-01:52] History of the specialty drug market
[01:53-02:43] Categorizing specialty drugs
[02:44-03:26] When UTMB decided to start a specialty program
[03:27-04:18] Building the program
[04:19-05:25] Benefits of the program
[05:26-06:11] Unexpected issues
[06:12-06:54] Where specialty pharmacy is going
[06:55-07:37] Advice for other starting specialty pharmacy programs
[07:38-08:21] Reasons to start a specialty pharmacy
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Android
RSS Feed -
A New Spin on Pharmacy Spend
Health system margins are shrinking making pharmacy spend a growing opportunity target. MultiCare Health System departs from historical methods with an exciting, multifaceted approach to the issue. Dr. Tyson Frodin, Assistant Vice President Pharmacy Supply Chain, Rev Cycle, Technology MultiCare Health System-Pharmacy Services, joins Gretchen Brummel, Pharmacy Executive Director in the Vizient Center for Pharmacy Practice Excellence and your program host to give his thoughts on this issue.
Guest speakers:
Tyson Frodin, PharmD, MHA, FACHE
Assistant Vice President
Pharmacy Supply Chain, Rev Cycle, Technology
MultiCare Health System-Pharmacy Services
Host:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
Show Notes:
[00:46-01:31] Dr. Tyson Frodin background information
[01:32-02:39] What drove the need for MultiCare’s pharmacy spend initiative
[02:40-08:42] Multi-pronged plan for MultiCare’s pharmacy spend initiative
[08:43-10:20] What surprised MultiCare about the process
[10:21-11:25] Outcomes
[11:26-13:11] Advice they have for other pharmacies who may wanna attempt something like this
[13:12-15:06] What’s in the future for MultiCare
Links | Resources:
Coming soon – New Pharmacy Portal and Pharmacy Analytics platform
We're excited to announce the launch of our new Pharmacy Portal on March 25th, alongside the rebranding of Vizient Savings Actualyzer – Pharmacy (VSAP) to Pharmacy Analytics.
The Pharmacy Portal is designed to be a comprehensive hub, offering a wide range of pharmacy tools and metrics, all accessible in one convenient location. With the rebranding to Pharmacy Analytics, we're introducing upgraded features and functionalities aimed at optimizing contract management, benchmarking spend, evaluating drug shortages and much more.
Join our webinar on March 27, Navigating Vizient Pharmacy Analytics with PMO projections and data, to learn more about the features and benefits of our new Pharmacy Portal and rebranded Pharmacy Analytics platform.
Plus, we will be hosting deeper dive sessions March 18 through April 5 where you can experience the new tools and ask questions of our pharmacy analytics experts. Learn more and sign up for one or multiple sessions.
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Android
RSS Feed -
505b2 Pathway: Ghost Generics
The 1984 Hatch-Waxman Act codified the 505(b)(2) drug approval pathway and allowed the use of studies from a previously approved drug. To be clear, medications approved via this pathway are not generic molecules of the reference listed drug. They may have similar clinical effects and roles in therapy, but they also bring challenges. Dr. Tyler Wood, System Director of Pharmacy Oncology and Biosimilars, and Pharmacy Executive Director, Carolyn Liptak at Vizient, join Gretchen Brummel, Pharmacy Executive Director in the Vizient Center for Pharmacy Practice Excellence and your program host to give an early look.
Guest speakers: Tyler Wood, PharmD, BCBBSSystem Director, Pharmacy Oncology and Biosimilars Providence St. Joseph Health
Carolyn Liptak, MBA, BSPharmPharmacy Executive Director Vizient
Host: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence
Show Notes:
[00:55-01:34] Dr. Tyler Wood background information
[01:35-03:09] How the 505(b)(2) pathway is intended to work
[03:10-04:32] Comparisons can we draw from the biologics approval process
[04:33-05:53] What the FDA says about which pathway to use
[05:54-07:05] What's changed recently in the approval process
[07:06-08:09] Can a 505(b)(2) product be rated as a generic equivalent?
[08:10 -09:07] How CMS changes are impacting management
[09:08-11:23] What our providers can do to plan and act to address these issues
[11:24-12:27] What’s most concerning moving forward
Links | Resources:
Applications Covered by 505(b)(2)
Hospital Outpatient Prospective Payment System: January 2024 Update
MLN Matters® Articles Sign-up
CMS.gov ASP Pricing Files
CMS.gov What's a MAC
Drugs@FDA: FDA-Approved Drugs
FDA: Overview of the 505(b)(2) Regulatory Pathway for New Drug Applications
HCPCS Level II Coding for 505(b)(2)-Approved Drugs or Biologicals – Frequently Asked Questions
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Android
RSS Feed
-
What’s pneu part 2: pneumococcal vaccines update
Pneumococcal vaccines have been instrumental in decreasing invasive disease since their introduction in the 1980s. 2021 brought regulatory changes and recent ACIP recommendations were published in the Morbidity and Mortality Weekly Report, also known as MMWR. Dr. John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information shares his insights on these changes with host Gretchen Brummel.
Guest speaker: John Schoen, PharmD, BCPSSenior Clinical Manager of Evidence-Based Medicine and Drug Information Vizient Center for Pharmacy Practice Excellence Host: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence
Show Notes:
Recorded in the Fall of 2023
[01:00-03:34] What’s new since March 2022 with pneumococcal vaccines
[03:35-06:51] Changes with the adult recommendations
[06:52-13:10] New recommendations from CDC as well as published recommendations for adults
[13:11-19:05] Recommendations for Pneumococcal vaccines in pediatrics
[19:06-21:46] The area of biggest risk moving forward
[21:47-24:07] What we are looking at for the future
Links | Resources:
Vizient pneumococcal vaccine side-by-side comparison Click Here
ACIP pneumococcal vaccine recommendations Click Here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Android
RSS Feed